⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1930706 | 0.67 | — | — | |
| SCHEMBL14401600 | 0.66 | — | — | |
| SCHEMBL14140296 | 0.63 | — | — | |
| SCHEMBL14138261 | 0.63 | — | — | |
| SCHEMBL172482 | 0.63 | — | — | |
| SCHEMBL8036365 | 0.62 | — | — | |
| SCHEMBL1304042 | 0.62 | — | — | |
| SCHEMBL19528602 | 0.62 | — | — | |
| SCHEMBL911012 | 0.62 | — | — | |
| SCHEMBL790988 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109575342-A | A kind of synthetic method of novel photoactive dry film acrylic resin | 湖南鸿瑞新材料股份有限公司 | 2019-04-05 | — | — | CN | claimed |
| CN-109491205-A | A kind of Photosensitve resin composition and preparation method thereof | 湖南鸿瑞新材料股份有限公司 | 2019-03-19 | — | — | CN | claimed |
| CN-1639151-A | Novel azepane derivatives | HOFFMANN LA ROCHE (CH) | 2005-07-13 | — | — | CN | claimed |
| EP-4393905-A1 | SALICYLIC ACID PRODUCTION METHOD | API Corporation (JP) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023229020-A1 | ELECTRODE COMPOSITION AND BATTERY | パナソニックホールディングス株式会社 | 2023-11-30 | — | — | WO | disclosed |
| WO-2023183852-A9 | PHOSPHONATE PRODRUGS AND USE THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2023-11-23 | — | — | WO | disclosed |
| CN-117015530-A | Urolithin derivatives and methods of use thereof | 范徳利亚股份公司 | 2023-11-07 | — | — | CN | disclosed |
| US-11779013-B2 | Stabilized peroxyacid solutions | EVONIK CORPORATION (US) | 2023-10-10 | — | — | US | disclosed |
| EP-3398983-B1 | POLYMER OF POLYIMIDE PRECURSOR, POSITIVE TYPE PHOTOSENSITIVE RESIN COMPOSITION, NEGATIVE TYPE PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING PROCESS, METHOD FOR FORMING CURED FILM, INTERLAYER INSULATING FILM, SURFACE PROTECTIVE FILM, AND ELECTRONIC PARTS | SHINETSU CHEMICAL CO (JP) | 2023-09-27 | — | — | EP | disclosed |
| CN-116782996-A | Tautomeric ligands enable biomimetic C-H hydroxylation under molecular oxygen | 斯克里普斯研究学院 | 2023-09-19 | — | — | CN | disclosed |
| EP-4238959-A1 | METHOD FOR PREPARING THIOMETHYLPHENOL DERIVATIVE | Korea Kumho Petrochemical Co., Ltd. (KR) | 2023-09-06 | — | — | EP | disclosed |
| WO-2002048105-A2 | ARYLOXY PIPERIDINYL DERIVATIVES FOR THE TREATMENT OF DEPRESSION | WYETH (US) | 2002-06-20 | — | — | WO | disclosed |
| US-20020038047-A1 | Process to separate linear alkyl 5-formylvalerate | DSM IP ASSETS B.V. (NL) | 2002-03-28 | — | — | US | disclosed |
| EP-1169290-A1 | PROCESS TO SEPARATE LINEAR ALKYL 5-FORMYLVALERATE | DSM N.V. (NL) | 2002-01-09 | — | — | EP | disclosed |
| CN-1304403-A | N-aryloxyethyl-indoly-alkylamines for treatment of depression (5-HT1A receptor active agents) | AMERICAN HOME PROD (US) | 2001-07-18 | — | — | CN | disclosed |
| CN-1303373-A | N-Aryloxyethylamine derivatives for treatment of depression | AMERICAN HOME PROD (US) | 2001-07-11 | — | — | CN | disclosed |
| WO-2000048984-A1 | PROCESS TO SEPARATE LINEAR ALKYL 5-FORMYLVALERATE | DSM N.V. (NL) | 2000-08-24 | — | — | WO | disclosed |
| US-5389401-A | Chemical vapor deposition of metal oxides | GORDON ROY G (US) | 1995-02-14 | — | — | US | disclosed |
| US-5326440-A | Carbonylation, peroxidation or hydroxylation of cyclohexene or tetralin; radiation | TEXACO INC. (US) | 1994-07-05 | — | — | US | disclosed |
| EP-0129478-A2 | 2-Sulfamoylbenzo (b) thiophene derivatives, their preparation and pharmaceutical composition for the treatment of elevated intraocular pressure | MERCK & CO. INC. (US) | 1984-12-27 | — | — | EP | disclosed |